Owens & Minor Inc. (NYSE: OMI) stock soared 6.68% to trade at $7.39 in Friday's pre-market session, following the company's better-than-expected fourth quarter 2024 earnings results and the announcement of a potential sale process for its Products & Healthcare Services segment.
The healthcare logistics company reported adjusted earnings per share of $0.55 for the fourth quarter, beating the consensus estimate of $0.52. Owens & Minor's revenue of $2.70 billion also topped analysts' expectations of $2.69 billion.
In the earnings release, Owens & Minor revealed that it is actively engaged in "robust discussions regarding the potential sale of its Products & Healthcare Services segment." The company stated that this move aligns with its strategy to focus on its higher-growth and higher-margin Patient Direct segment.
For the full year 2025, Owens & Minor expects revenue in the range of $10.85 billion to $11.15 billion, adjusted EBITDA between $560 million and $590 million, and adjusted EPS of $1.60 to $1.85. The company's guidance excludes any impact from the potential sale of the Products & Healthcare Services segment or the previously announced acquisition of Rotech.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.